Recombinant Mouse AP2A2 Protein Pre-coupled Magnetic Beads
Cat.No. : | AP2A2-601M-B |
Product Overview : | The Recombnant protein was conjugated to magnetic beads. This ready-to-use, pre-coupled magnetic beads are in uniform particle size and narrow size distribution with large surface area, which is conducive to convenient and fast capture target molecules with high specificity and achieve magnetic separation. This product can be equipped with automation equipment for high-throughput operations. |
- Specification
- Gene Information
- Related Products
- Download
Source : | HEK293 |
Species : | Mouse |
Form : | Solution |
Particle size : | ~2 μm |
Beads Surface : | Hydrophilic |
Capacity : | > 200 pmol rabbit IgG/ mg beads |
Applications : | Immunoassay, In vitro diagnostics, cell sorting, Immunoprecipitation/Co-precipitation, Protein/antibody separation and purification. |
Stability : | Stable for at least 6 months from the date of receipt of the product under proper storage and handling conditions. |
Storage : | 2-8℃. Do not to freeze thaw the Beads |
Concentration : | 10mg beads/mL |
Storage Buffer : | PBS buffer |
Gene Name : | Ap2a2 adaptor protein complex AP-2, alpha 2 subunit [ Mus musculus ] |
Official Symbol : | AP2A2 |
Gene ID : | 11772 |
mRNA Refseq : | NM_007459.3 |
Protein Refseq : | NP_031485.3 |
UniProt ID : | P17427 |
Products Types
◆ Recombinant Protein | ||
AP2A2-601M | Recombinant Mouse AP2A2 Protein, His (Fc)-Avi-tagged | +Inquiry |
AP2A2-9715H | Recombinant Human AP2A2, His-tagged | +Inquiry |
Ap2a2-3531R | Recombinant Rat Ap2a2, His-tagged | +Inquiry |
AP2A2-3532H | Recombinant Human AP2A2, His-tagged | +Inquiry |
AP2A2-1739M | Recombinant Mouse AP2A2 Protein | +Inquiry |
◆ Lysates | ||
AP2A2-8816HCL | Recombinant Human AP2A2 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Reviews
- Q&As
Customer Reviews (4)
Write a reviewThe sensitivity of AP2A2 in Western blot is very high, and low concentrations of the target protein can be detected.
I appreciate the production process of AP2A2, every step is strictly controlled to ensure the quality and repeatability of the product.
Under different pH conditions, the stability of this protein is still very good, indicating that it has excellent acid-base stability.
AP2A2 are structurally stable and not prone to mutation.
Q&As (19)
Ask a questionRecombinant AP2A2 may play an antitumor role by inhibiting tumor growth and promoting autoimmunity.
Normally, AP2A2 injections should be stored in the refrigerator at a temperature of 2-8 ° C.
Recombinant AP2A2 therapy can be administered intravenously or intramuscularly.
Generally, the preparation methods of AP2A2 include recombinant DNA technology and protein expression and purification technology.
At present, the recombinant AP2A2 protein is still in clinical trials, and researchers are evaluating its safety and efficacy.
There are no clear studies showing that the AP2A2 improves patients' quality of life, but its therapeutic effect may vary for individuals.
Recombinant AP2A2 protein may regulate immune cell activity and enhance immune response, but the specific mechanism still needs to be further studied.
While some studies have shown that recombinant AP2A2 has a preventive effect, more research is needed to confirm its effectiveness.
The study of AP2A2 still faces challenges in terms of safety, efficacy and stability.
Although some preliminary studies suggest that recombinant AP2A2 may have a therapeutic effect on autoimmune diseases, more clinical trials are needed to determine its efficacy.
Evaluation of the effectiveness of AP2A2 therapy usually includes clinical symptom improvement, biomarker level detection, etc.
No definite side effects have been reported, but please consult your doctor before receiving treatment.
The indication for the treatment of AP2A2 needs to be determined based on the specific disease and individual patient situation. Consult your doctor for more accurate advice.
The duration of treatment for AP2A2 varies according to the purpose of treatment and individual differences, please consult your doctor for details.
Currently, the AP2A2 shows potential in the treatment of certain cancers and autoimmune diseases.
There is no clear clinical limit to its use, but different diseases and individual conditions may affect its therapeutic effectiveness.
There are no clear studies showing that recombinant AP2A2 has a therapeutic effect on non-immune-related diseases.
Recombinant protein AP2A2 is mainly involved in intracellular material transport and endocytosis.
Some studies have shown that recombinant AP2A2 can inhibit the growth and spread of certain cancer cells, but further clinical studies are needed to verify its therapeutic effect.
Ask a Question for All AP2A2 Products
Required fields are marked with *
My Review for All AP2A2 Products
Required fields are marked with *
Inquiry Basket